UpSurgeOn Raises €5 Million to Advance Surgical Training Technologies
[Milan, Lombardy, Italy] — UpSurgeOn, a company dedicated to enhancing the cognitive and psychomotor skills of surgeons through a combination of virtual and physical technologies, has successfully raised €5 million in its latest funding round. The investment was led by CDP Venture Capital, with participation from SIMEST, Deep Blue Ventures, Azimut Libera Impresa SGR, and FBH S.p.A. The funding was finalized on March 22, 2026.
Company Background
Founded by Federico Nicolosi, who also serves as the CEO, and co-founder Giannantonio Spena, UpSurgeOn is focused on providing advanced training solutions for surgeons. The company’s platform, UpSurgeOn Academy, is designed to support both mental and manual training, leveraging cutting-edge technologies to improve the skills of medical professionals.
Investment Details
The recent funding round, though undisclosed in terms of its specific series, marks a significant step for UpSurgeOn as it seeks to expand its reach and capabilities. CDP Venture Capital took the lead in this round, further supported by other notable investors such as SIMEST, Deep Blue Ventures, Azimut Libera Impresa SGR, and FBH S.p.A.
Planned Use of Funds
While specific plans for the newly acquired capital have not been detailed, it is expected that UpSurgeOn will utilize the funds to enhance its technological offerings and possibly expand its market presence. This could involve further development of their training platforms and increasing accessibility to their technologies for surgeons worldwide.
Leadership Comments
Though no direct quotes from the executives were provided, the involvement of such a diverse group of investors suggests confidence in the leadership of Nicolosi and Spena and their vision for the future of surgical training.
Conclusion
UpSurgeOn’s latest funding round is a testament to the growing interest in innovative medical training solutions. With the backing of prominent investors, the company is well-positioned to make significant strides in the development of technologies that empower surgeons globally.